This inventor holds 6 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Leland Stanford Junior University, Aravive Biologics, Inc.. Active years: 2013-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Waltham, MA (US) (2013 - 2018)
- Redwood City, CA (US) (2021)
Company Filing History:
6 out of 5,515 
3 out of 5 Years Active: 2013-2021
Title: The Innovative Contributions of Erinn Bruno Rankin
Introduction
Erinn Bruno Rankin is a notable inventor based in Waltham, MA, who has made significant contributions to the field of biotechnology. With a total of six patents to his name, Rankin's work primarily focuses on therapeutic applications aimed at combating various diseases, including cancer and liver fibrosis.
Latest Patents
Among his latest patents, Rankin has developed modified AXL peptides that inhibit AXL signaling in anti-metastatic therapy. This innovative approach provides compositions and methods for alleviating cancer in mammals by administering a pharmaceutical composition that inhibits the activity of AXL, MER, or Tyro3 protein activity. This is achieved through competitive or non-competitive inhibition of the binding interaction between these proteins and their ligand, GAS6. Another significant patent addresses the inhibition of AXL/GAS6 signaling in the treatment of liver fibrosis. This patent outlines methods for alleviating endometriosis, kidney disease, inflammatory disease, and transplant rejection by administering a therapeutic dose of a pharmaceutical composition that inhibits AXL, MER, or Tyro3 protein activity.
Career Highlights
Throughout his career, Rankin has worked with prestigious institutions, including Leland Stanford Junior University and Aravive Biologics, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field, further enhancing his innovative contributions.
Collaborations
Rankin has collaborated with notable professionals such as Amato J Giaccia and Jennifer R Cochran, which has enriched his research and development efforts.
Conclusion
Erinn Bruno Rankin's innovative work in biotechnology, particularly in the development of therapeutic applications for cancer and liver fibrosis, showcases his significant contributions to the field. His patents reflect a commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile